An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence.

Haematologica · 2023 · PMC10071131 · PMID 36325890

Europe PMC DOI

hedged sentence

0.0245

closest p · 0.5× alpha

0.0245

boldest claim

The sentences

highly significantP =0.0245actually significant

Of note, 3-year OS and PFS in fit/intermediate versus frail patients showed highly significant differences of 86% (95% CI: 81-90) versus 70% (95% CI: 47-85) and 57% (95% CI: 50-63) versus 21% (95% CI: 6-41), respectively ( P =0.0245/ P <0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.